University of Missouri-Columbia School of Health Professions Link to MU Homepage link to MU Homepage School of Health Professions
Virtual Health Care Team
Case StudiesAbout VHCTContinuing EducationHealth ReferencesContact UsHome


Harleen Jaggi, BS, MT (ASCP), CLS (NCA)

Ellen Hope Kearns, MS, SH(ASCP)H

Quest Diagnostics Inc., San Juan Capistrano, CA, and

Division of Health Sciences, School of Health, California State University Dominguez Hills

Risk Factors in Coronary Artery Disease


  1. Bachorik PS, Ross JW. National Cholesterol Education Program recommendations for measurement of low-density lipoprotein cholesterol: executive summary. Clin Chem 1995; 41(10): 1414-20.
  2. Stein EA, Myers GL. National Cholesterol Education Program recommendations for triglycerides measurement: executive summary. Clin Chem 1995; 41(10): 1421-6.
  3. Anti-Lipemic Agents. Quick Reference Chart. Teterboro NJ: Quest Diagnostics Incorporated; 1999.
    Anti-lipemic agents
  4. Hoeg JM. Evaluating coronary heart disease risk. JAMA 1997; 277(17): 1387-90.
    [Published erratum appears in JAMA 1997;278(8):636.]
  5. Smith SC Jr. Lessons from cholesterol-lowering trials. Am J Med 1998; 104(6A): 28S-32S.
  6. Hoyert DL, Kochanek KD, Murphy SL. Deaths: final data for 1997. National vital statistics reports 1999; 47(19): 5.
  7. May LA. The physiologic and psychological bases of health, disease and care seeking. In: William SJ, Torrens PR, editors. Introduction to Health Services. 5th ed. Albany, NY: Delmar; 1999. p. 39-57.
  8. Bachorik PS, Levy RI, Refkind BM. Lipids and dyslipoprotenemia. In: Henry JB, editor. Clinical Diagnosis and Management by Laboratory Methods. 18th ed. Philadelphia, PA: WB Saunders; 1991. p. 188-214.
  9. Manson JE, Tosteson H, Ridker PM, Satterfield S, Herbert P, O'Connor GJ, Buring JE, Hennekens CH. The primary prevention of myocardial infarction. N Engl J Med 1992; 326(21): 1406-16.
  10. Gotto AM Jr. Triglyceride as risk factor for coronary artery disease. Am J Cardiol 1998; 82(9A): 22Q-25Q. (Abstract)
  11. Stampfer MJ, Krauss RM, Ma J, Blanche PJ, Holl LG, Sacks FM, Hennekens CH. A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA 1996; 276(11): 882-8.
  12. Frishman WH. Biologic markers as predictors of cardiovascular disease. Am J Med 1998; 104(6A): 18S-27S.
  13. Scanu AM. Lipoprotein (a). A genetic risk factor for premature coronary heart disease. JAMA 1992; 267(24): 3326-9.
  14. Hokanson JE, Austin MA, Brunzell JD. Measurement and clinical significance of low-density lipoprotein subclasses. In: Rifai N, Warnick GR, Dominiczak MH, editors. Handbook of Lipoprotein Testing. Washington DC: AACC press; 1997. p. 267-79.
  15. Slyper AH. Low-density lipoprotein density and atherosclerosis: Unraveling the connection. JAMA 1994; 272(4):305-8.
  16. Swinkels DW, Demacker PN, Hendricks JC, van 't Laar A. Low density lipoprotein subfractions and relationship to other risk factors for coronary artery disease in healthy individuals. Arteriosclerosis 1989; 9(5): 604-13. (Abstract)
    [Published erratum appears in Arteriosclerosis 1990;10(3):491.]


Congestive Heart Failure
From Merck

Gillinov M., Nissen S. Heart 411. Three Rivers, 2012. Review.

Heart Failure
From Wikipedia

Video on causes of congestive heart failure.

Women and CAD
45 minute video from the Cleveland Clinic.

Published by the Virtual Health Care Team ®
School of Health Professions
University of Missouri-Columbia
Questions? Comments? Contact Us
Copyright © 2005-2012 — Curators of the University of Missouri
DMCA and other copyright information.
An equal opportunity/ADA institution.
All rights reserved. Disclaimer and Terms of Use
Last Update: September 11 2012